1. The perennial search for alternatives to corticosteroids in rheumatology: is there light at the end of the tunnel?

   • Durga Prasanna Misra
   • Vikas Agarwal

   Editorial 22 August 2020 Pages: 2845 - 2848

2. Gout: a disease involved with complicated immunoinflammatory responses: a narrative review

   • Meimei Wu
   • Ye Tian
   • Chengshan Guo

   Review Article 07 May 2020 Pages: 2849 - 2859

   

3. Rheumatoid arthritis and osteoarthritis clinical practice guidelines provide few complementary and alternative medicine therapy recommendations: a systematic review

   • Jeremy Y. Ng
   • Ashlee M. Azizudin

   Review Article 08 May 2020 Pages: 2861 - 2873

   

4. Role of HLA-DRB1*04 in the susceptibility and HLA-DRB1*08 in the protection for development of rheumatoid arthritis in a population of Southern Mexico: brief report

   • Sepúlveda-Delgado J.
   • Rizo-Pinto A.
   • L. J. Jara-Quezada

   Brief Report 02 April 2020 Pages: 2875 - 2879

5. TGF-β1 +869C/T polymorphism increases susceptibility to rheumatoid arthritis in North Indian population

   • Sipahee Lal Patel
   • Jaya Prakash
   • Varsha Gupta

   Original Article 08 April 2020 Pages: 2881 - 2888

6. Validation and implementation of a patient-reported experience measure for patients with rheumatoid arthritis and spondyloarthritis in the Netherlands

   • Esther Beckers
   • Casper Webers
   • Astrid van Tubergen

   Original Article Open access 21 April 2020 Pages: 2889 - 2897

7. Profile of common inflammatory markers in treatment-naïve patients with systemic rheumatic diseases

   • Min Jung Kim
   • Eun Bong Lee
   • Jin Kyun Park

   Original Article 20 April 2020 Pages: 2899 - 2906

   

8. Propensity score matching/reweighting analysis comparing intravenous golimumab to infliximab for ankylosing spondylitis using data from the GO-ALIVE and ASSERT trials

   • L. S. Gensler
   • S. D. Chakravarty
   • A. Deodhar

   Original Article Open access 04 May 2020 Pages: 2907 - 2917

   

9. Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain

   • F. Navarro
   • J. M. Martinez-Sesmero
   • Itziar Oyagüez

   Original Article Open access 17 April 2020 Pages: 2919 - 2930

   

10. Preferences for treatments to prevent rheumatoid arthritis in Canada and the influence of shared decision-making

    • Mark Harrison
    • Nick Bansback
    • Marie Hudson

    Original Article 04 April 2020 Pages: 2931 - 2941

    

11. Overall survival in patients with rheumatoid arthritis and solid malignancies receiving biologic disease-modifying antirheumatic therapy

    • Xerxes Pundole
    • Natalia V. Zamora
    • Maria E. Suarez-Almazor

    Original Article 15 August 2020 Pages: 2943 - 2950

    

12. Elevated CRP even at the first visit to a rheumatologist is associated with long-term poor outcomes in patients with psoriatic arthritis

    • Muhammad Haroon
    • Phil Gallaghar
    • Oliver FitzGerald

    Original Article 02 April 2020 Pages: 2951 - 2961

13. Effectiveness of ustekinumab in patients with psoriatic arthritis in a real-world, multicenter study

    • A. B. Azuaga
    • B. Frade-Sosa
    • on behalf of ESPOCAT group

    Original Article 13 April 2020 Pages: 2963 - 2971

    

14. Enthesitis and joint erosions are disease traits associated with cardiovascular risk in psoriatic arthritis

    • Andrés Lorenzo
    • Estefanía Pardo
    • Rubén Queiro

    Original Article 20 April 2020 Pages: 2973 - 2979

    

15. Patients with psoriatic arthritis have higher levels of FeNO than those with only psoriasis, which may reflect a higher prevalence of a subclinical respiratory involvement

    • Giovanni Damiani
    • Alessia Pacifico
    • Abdulla Watad

    Original Article 02 April 2020 Pages: 2981 - 2988

    

16. Challenges in physician-patient communication for optimal management of systemic sclerosis-associated interstitial lung disease: a discourse analysis

    • Christopher P. Denton
    • Bee Laird
    • Jose Luis Luna Flores

    Original Article Open access 13 April 2020 Pages: 2989 - 2998

    

17. Higher risk of Parkinson disease in patients with primary Sjögren’s syndrome

    • Hui-Ching Hsu
    • Tsung-Yun Hou
    • Jin Hua Chen

    Original Article 02 April 2020 Pages: 2999 - 3007

    

18. Definite IgG4-related disease had no overlap with eosinophilic granulomatosis with polyangiitis in Korean patients: a pilot study in one centre

    • Juyoung Yoo
    • Jason Jungsik Song
    • Sang-Won Lee

    Original Article 04 May 2020 Pages: 3009 - 3015

19. Is axial magnetic resonance imaging useful in early juvenile spondyloarthritis—preliminary report

    • Ana Tripalo Batoš
    • Kristina Potočki
    • Alenka Gagro

    Original Article 15 April 2020 Pages: 3017 - 3025

    

20. Clinical manifestations of Kawasaki disease in different age groups: retrospective data from Southwest China

    • Lianjie Shi
    • Jianhong Li
    • Lina Qiao

    Original Article 04 May 2020 Pages: 3027 - 3032

21. Long-term opioid use among patients with chronic gout: a cross-sectional study of a sample cohort in South Korea

    • Tak Kyu Oh
    • In-Ae Song

    Original Article 04 May 2020 Pages: 3033 - 3039

    

22. Cross-cultural adaption and validation of simplified Chinese version of the lower extremity function scale in patients with knee osteoarthritis

    • Ling Xu
    • Chen Wang
    • Wenwen Tong

    Original Article 21 April 2020 Pages: 3041 - 3048

23. Structural severity, phase angle, and quadriceps strength among patients with knee osteoarthritis: the SPSS-OK study

    • Osamu Wada
    • Noriaki Kurita
    • Kiyonori Mizuno

    Original Article 27 April 2020 Pages: 3049 - 3056

    

24. Comparison of the short-term results of single-dose intra-articular peptide with hyaluronic acid and platelet-rich plasma injections in knee osteoarthritis: a randomized study

    • Fatma Nur Kesiktas
    • Bahar Dernek
    • Merve Yildiz

    Original Article Open access 01 May 2020 Pages: 3057 - 3064

    

25. Clinical features, risk factors, and outcomes of septic arthritis in patients on maintenance hemodialysis

    • Jianna Zhang
    • Xiaohan You

    Brief Report 08 May 2020 Pages: 3065 - 3069

26. Infective patterns of cryptococcosis in patients with connective tissue disease: a retrospective study

    • Minxi Lao
    • Yingying Gong
    • Dongying Chen

    Original Article 03 April 2020 Pages: 3071 - 3081

    

27. Challenges to optimal rheumatology care: a patient-centered focus group study

    • J. Dollinger
    • C. Neville
    • S. Bernatsky

    Original Article 25 April 2020 Pages: 3083 - 3090

28. Therapeutic effects of proprioceptive exercise on functional capacity, anxiety, and depression in patients with diabetic neuropathy: a 2-month prospective study

    • Walid Kamal Abdelbasset
    • Saud M. Alrawaili
    • Ahmed S. Ahmed

    Original Article 16 April 2020 Pages: 3091 - 3097

    

29. Rituximab or cyclosporin in refractory immune thrombocytopenia secondary to connective tissue diseases: a real-world observational retrospective study

    • Fangfang Sun
    • Jie Chen
    • Shuang Ye

    Brief Report 16 May 2020 Pages: 3099 - 3104

    

30. Comparison of 8-year knee osteoarthritis progression in 2 siblings: a case-based review

    • Margaret L. Gourlay
    • Linda L. Gourlay

    Case Based Review Open access 26 May 2020 Pages: 3105 - 3113

    

31. Giant cell arteritis with normal inflammatory markers: case report and review of the literature

    • Patrícia Martins
    • Vítor Teixeira
    • Cristina Ponte

    Case Based Review 29 May 2020 Pages: 3115 - 3125

    

32. Ruptured hemorrhagic corpus luteum as a presenting symptom of systemic lupus erythematous

    • Itamar Feldman
    • Bnaya Alon
    • Gabriel S. Breuer

    Case Based Review 01 June 2020 Pages: 3127 - 3129

33. Certain perspectives about the use of corticosteroids for managing hospitalized patients with rheumatic diseases

    • Sky Wang
    • Richard S. Panush

    Perspectives in Rheumatology 24 August 2020 Pages: 3131 - 3136

34. Osteonecrosis of the lunate in systemic sclerosis—an underappreciated vascular complication?

    • Robert D. Sandler
    • Adrian M. Highland
    • Michael Hughes

    Clinical Image 16 May 2020 Pages: 3137 - 3138

    

35. A 9-year-old girl with Kawasaki disease and pulmonary nodules

    • Yousuke Higuchi
    • Motoharu Ochi
    • Mahoko Furujo

    Clinical Image 12 June 2020 Pages: 3139 - 3140

    

36. Diplopia and ocular pain due to orbital myositis

    • Rosa I. Arvizu-Rivera
    • Rita A. Pineda-Sic
    • Miguel A. Villarreal-Alarcon

    Clinical Image 23 June 2020 Pages: 3141 - 3142

    

37. Distinct gene network in skin lesion of patients with diffuse cutaneous systemic sclerosis

    • Jun Inamo

    Letters of Biomedical and Clinical Research 25 June 2020 Pages: 3143 - 3144

    

38. Cerebrospinal fluid levels of BAFF and APRIL as direct indicators of disease activity in anti-neutrophil cytoplasmic antibody–related hypertrophic pachymeningitis

    • Yasuhiro Shimojima
    • Dai Kishida
    • Yoshiki Sekijima

    Letters of Biomedical and Clinical Research 04 July 2020 Pages: 3145 - 3148

    

39. Biosimilars for vasculitis: promise requires validation by quality studies

    • Durga Prasanna Misra
    • Pallavi Patro
    • Vikas Agarwal

    Letter to the Editor 31 July 2020 Pages: 3149 - 3151

40. Is it time to say goodbye to weekly rituximab in ANCA vasculitis?

    • Benzeeta Pinto
    • Aadhaar Dhooria

    Letter to the Editor 26 August 2020 Pages: 3153 - 3154

41. Response to: Biosimilars for vasculitis: promise requires validation by quality studies

    • Sakshi Mittal
    • G. S. R. S. N. K. Naidu
    • Aman Sharma

    Letter to the Editor 02 September 2020 Pages: 3155 - 3156

42. Correction to: Comparison of 8-year knee osteoarthritis progression in 2 siblings: a case-based review

    • Margaret L. Gourlay
    • Linda L. Gourlay

    Correction Open access 15 July 2020 Pages: 3157 - 3157

43. Correction to: The IgG galactosylation ratio is higher in spondyloarthritis patients and associated with the MRI score

    • Jing Liu
    • Qi Zhu
    • Jiucun Wang

    Correction 05 August 2020 Pages: 3159 - 3159

44. Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data

    • Chak Sing Lau
    • Yi-Hsing Chen
    • Kevin Winthrop

    Correction 02 September 2020 Pages: 3161 - 3161